Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults

Background. Vaccines against norovirus, the leading cause of acute gastroenteritis, should protect against medically significant illness and reduce transmission. Methods. In this randomized, double-blind, placebo-controlled trial, 18- to 50-year-olds received 2 injections of placebo or norovirus GI....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Infect Dis
Hauptverfasser: Bernstein, David I., Atmar, Robert L., Lyon, G. Marshall, Treanor, John J., Chen, Wilbur H., Jiang, Xi, Vinjé, Jan, Gregoricus, Nicole, Frenck, Robert W., Moe, Christine L., Al-Ibrahim, Mohamed S., Barrett, Jill, Ferreira, Jennifer, Estes, Mary K., Graham, David Y., Goodwin, Robert, Borkowski, Astrid, Clemens, Ralf, Mendelman, Paul M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2015
Schlagworte:
Major Articles and Brief Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5914500/
https://ncbi.nlm.nih.gov/pubmed/25210140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu497
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge